Noninvasive ventilation for acute hypoxemic respiratory failure in patients with COVID-19

…, AI Yaroshetskiy, NA Tsareva, ZM Merzhoeva… - The American journal of …, 2021 - Elsevier
Aim Noninvasive ventilation (NIV) is known to reduce intubation in patients with acute
hypoxemic respiratory failure (AHRF). We aimed to assess the outcomes of NIV application in …

[HTML][HTML] Low prevalence of bronchial asthma and chronic obstructive lung disease among intensive care unit patients with COVID‐19

…, K Umbetova, L Akulkina, N Tsareva, Z Merzhoeva… - Allergy, 2020 - ncbi.nlm.nih.gov
To the Editor, In a recent article, Li et al reported low prevalence of bronchial asthma (0.9%)
among 548 hospitalized patients with COVID-19 and suggested that Th2 immune response …

Anti-IL-17 monoclonal antibodies in hospitalized patients with severe COVID-19: A pilot study

…, NA Tsareva, AI Yaroshetskiy, ZM Merzhoeva… - Cytokine, 2021 - Elsevier
Background One of the main pathophysiological mechanisms underlying the severe course
of COVID-19 is the hyper-inflammatory syndrome associated with progressive damage of …

[HTML][HTML] N-acetylcysteine for the treatment of COVID-19 among hospitalized patients

SN Avdeev, VV Gaynitdinova, ZM Merzhoeva… - The Journal of …, 2022 - ncbi.nlm.nih.gov
Stang and coworkers have recently reported in the Journal that “RT-PCR test results as gold
standard for assessing and controlling infectiousness fail”[1]. The authors analyzed two …

Clinical outcomes of patients with COVID-19 admitted for respiratory support to the intensive care units in Russia

…, V Kapustina, V Kraeva, Z Merzhoeva… - Klinicheskaya …, 2020 - pesquisa.bvsalud.org
Aim. To evaluate mortality and risk factors for death in patients with COVID-19 who required
admission to intensive care units (ICU) for respiratory support in Russia. Material and …

[HTML][HTML] Beneficial effects of inhaled surfactant in patients with COVID-19-associated acute respiratory distress syndrome

…, SY Chikina, NA Tsareva, ZM Merzhoeva… - Respiratory …, 2021 - Elsevier
Merzhoeva: performed the measurements and collected the data, analyzed the data and
interpreted the results. Andrey I. Yaroshetskiy: performed the measurements and collected the …

N-acetylcysteine as a part of complex treatment of moderate COVID-associated pneumonia

…, S Avdeev, Z Merzhoeva, Z Berikkhanov… - 2021 - covid19.neicon.ru
The need for safe and effective treatment is becoming increasingly urgent due to the high
COVID-19 mortality rates observed worldwide. The choice of drug products for COVID-19 …

[HTML][HTML] Predictors of progression and mortality in patients with chronic hypersensitivity pneumonitis: retrospective analysis of registry of fibrosing interstitial lung …

…, AI Yaroshetskiy, NB Nadtochiy, ZM Merzhoeva… - Life, 2023 - mdpi.com
Hypersensitivity pneumonitis (HP) is an interstitial lung disease (ILD) resulting from an
immune-mediated response in susceptible and sensitized individuals to a large variety of inhaled …

Risk factors for the early development of septic shock in patients with severe COVID-19

…, K Dubrovin, V Kapustina, V Kraeva, Z Merzhoeva… - 2021 - covid19.neicon.ru
Aim. In a retrospective study, we evaluated factors associated with the early development of
septic shock in patients with severe COVID-19. Materials and methods. We collected …

[HTML][HTML] Potential for the lung recruitment and the risk of lung overdistension during 21 days of mechanical ventilation in patients with COVID-19 after noninvasive …

…, AP Krasnoshchekova, ZM Merzhoeva… - BMC …, 2022 - Springer
Background Data on the lung respiratory mechanics and gas exchange in the time course
of COVID-19-associated respiratory failure is limited. This study aimed to explore respiratory …